BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6452060)

  • 1. FUdR induction of the X chromosome fragile site: evidence for the mechanism of folic acid and thymidine inhibition.
    Glover TW
    Am J Hum Genet; 1981 Mar; 33(2):234-42. PubMed ID: 6452060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined effects of FUdR addition and methionine depletion on the X-chromosome fragile site.
    Glover TW; Howard-Peebles PN
    Am J Hum Genet; 1983 Jan; 35(1):117-22. PubMed ID: 6218753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluoro-2'-deoxyuridine induction of the fragile site on Xq28 associated with X linked mental retardation.
    Tommerup N; Poulsen H; Brøndum-Nielsen K
    J Med Genet; 1981 Oct; 18(5):374-6. PubMed ID: 6460104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of fluorinated pyrimidine analogues in the induction of the in vitro expression of the fragile X chromosome.
    Vandamme B; Liebaers I; Hens L; Bernheim JL; Roobol C
    Hum Genet; 1988 Aug; 79(4):341-6. PubMed ID: 2970425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fragile X(q27) form of X-linked mental retardation: FUdR as an inducing agent for fra(X)(q27) expression in lymphocytes, fibroblasts, and amniocytes.
    Brookwell R; Daniel A; Turner G; Fishburn J
    Am J Med Genet; 1982 Oct; 13(2):139-48. PubMed ID: 6215863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fragile X chromosome: current methods.
    Hecht F; Jacky PB; Sutherland GR
    Am J Med Genet; 1982 Apr; 11(4):489-95. PubMed ID: 6211983
    [No Abstract]   [Full Text] [Related]  

  • 7. Variability of thymidylate synthase activity in whole blood cultures treated with FUdR.
    Sklower SL; Jenkins EC; Anderson ML; Chan CB; Brown WT
    Am J Med Genet; 1986; 23(1-2):483-90. PubMed ID: 2937302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidylate synthetase inhibitors and fragile site expression in lymphocytes.
    Jacky PB; Sutherland GR
    Am J Hum Genet; 1983 Nov; 35(6):1276-83. PubMed ID: 6228136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic investigations in mentally retarded and normal males from 14 families with the fragile site at Xq28. Results of folic acid treatment on fra(X) expression.
    Nielsen KB; Tommerup N
    Hum Genet; 1984; 66(2-3):225-9. PubMed ID: 6232199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro reversal of fragile-X expression by exogenous thymidine.
    Gardiner GB; Wenger SL; Steele MW
    Clin Genet; 1984 Feb; 25(2):135-9. PubMed ID: 6231141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of thymidylate synthesis increase whereas thymidine decreases meiotic recombination in Drosophila melanogaster.
    Silber J; Bazin C; Le Menn A
    Mol Gen Genet; 1985; 199(1):53-4. PubMed ID: 3158797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced sensitivity of lymphoblastoid cells from individuals carrying the mutation for the fragile X syndrome to the clastogenic effects of FUdR.
    Duncan AM
    Mutat Res; 1986 Mar; 173(3):201-5. PubMed ID: 2936953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of tri- or multiradial configurations in fragile X identification.
    Jenkins EC; Duncan CJ; Krawczun MS; Berns LM; Sanz MM; Brown WT
    Am J Med Genet; 1986; 23(1-2):531-5. PubMed ID: 2937304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidylate metabolism in fragile X syndrome cells.
    Wang JC; Erbe RW
    Somat Cell Mol Genet; 1985 Jul; 11(4):353-7. PubMed ID: 3895463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental chemotherapy of neuroblastoma. II. Increased thymidylate synthetase activity in a 5-fluorodeoxyuridine-resistant variant of mouse neuroblastoma.
    Baskin F; Carlin SC; Kraus P; Friedkin M; Rosenberg RN
    Mol Pharmacol; 1975 Jan; 11(1):105-17. PubMed ID: 123312
    [No Abstract]   [Full Text] [Related]  

  • 16. The induction of X-chromosomal aneuploidy by 5-fluorodeoxyuridine (FUdR) fed to Drosophila melanogaster females.
    Traut H
    Can J Genet Cytol; 1978 Jun; 20(2):259-63. PubMed ID: 151580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of the common fragile site at Xq27.2 under conditions of thymidylate stress: implications for cytogenetic diagnosis of the fragile-X syndrome.
    Ramos FJ; Emanuel BS; Spinner NB
    Am J Med Genet; 1992 Apr; 42(6):835-8. PubMed ID: 1532475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifolate-induced misincorporation of deoxyuridine monophosphate into DNA by cells from patients with the fragile X syndrome.
    Wang JC; Beardsley GP; Erbe RW
    Am J Med Genet; 1985 Aug; 21(4):691-6. PubMed ID: 2992271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excess thymidine induces folate sensitive fragile sites.
    Sutherland GR; Baker E; Fratini A
    Am J Med Genet; 1985 Oct; 22(2):433-43. PubMed ID: 4050872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and identification of folate-sensitive fragile sites in British Suffolk sheep (Ovis aries).
    Ali A; Abdullah M; Babar ME; Javed K; Nadeem A
    J Genet; 2008 Dec; 87(3):219-27. PubMed ID: 19147906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.